{"name":"Berkeley Eye Center","slug":"berkeley-eye-center","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Clareon PanOptix PRO","genericName":"Clareon PanOptix PRO","slug":"clareon-panoptix-pro","indication":"Cataract surgery with presbyopia correction (distance, intermediate, and near vision)","status":"marketed"},{"name":"Mix-and-Match PanOptix/Vivity","genericName":"Mix-and-Match PanOptix/Vivity","slug":"mix-and-match-panoptix-vivity","indication":"Cataract surgery with presbyopia correction in patients desiring multifocal or extended depth of focus vision","status":"marketed"}]}],"pipeline":[{"name":"Clareon PanOptix PRO","genericName":"Clareon PanOptix PRO","slug":"clareon-panoptix-pro","phase":"marketed","mechanism":"Clareon PanOptix PRO is a trifocal intraocular lens that provides simultaneous vision at multiple focal distances through diffractive optics.","indications":["Cataract surgery with presbyopia correction (distance, intermediate, and near vision)"],"catalyst":""},{"name":"Mix-and-Match PanOptix/Vivity","genericName":"Mix-and-Match PanOptix/Vivity","slug":"mix-and-match-panoptix-vivity","phase":"marketed","mechanism":"A mix-and-match intraocular lens combination that pairs PanOptix and Vivity multifocal/extended depth of focus technologies to optimize vision across multiple distances.","indications":["Cataract surgery with presbyopia correction in patients desiring multifocal or extended depth of focus vision"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HanBvS2JpRFYyOF9MSG5mNjdJVnloMVJCNWlxb3ZtczBrM1VrOENpRHdQZy1aWDJMeHM2X0tNWEpQbG9qZVlrYjkzaFRGYkdTa1lZbklabENnSVVaZ1NZ?oc=5","date":"2025-05-07","type":"trial","source":"Nature","summary":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 - Nature","headline":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOS19SVmpySk13ZkdESGVfVE9UR1hwYmF2VEdIRk1MNlp1amEzVUdiQzF6bHRrRkdDUnJ2VFlEQjJvTjlTRkJyZFpDMHVLQklTWTVpZENPWnAwMXg4MHFpY1N1S1M0d0QwaXRhMTdEcTM5OVdkVjBzXzM2dkUyMTdxb0R5cndkU2taZzdDaGJ3Smp2UzhmUElRSm13?oc=5","date":"2021-04-13","type":"pipeline","source":"Legacy","summary":"Ralph Berkeley Obituary (2021) - Houston, TX - Houston Chronicle - Legacy","headline":"Ralph Berkeley Obituary (2021) - Houston, TX - Houston Chronicle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPNkdjYzZDUTZ4SWQyV3VGWmc3M05WUTdLckRYZy1aN1d0ejJid2k0bFBfNlZUdlA2NHYxdmFsWFN6UTBIR18yNjVRYjhDUmZyRWE3OXktZGdzVFhYQW5vbVFCVWJJeU5SMXREYXM4Tm9DWV9jTk1FTXhVbmZHVTlIT2JNa2ZKR251YmpSeEgwV29BS2xrakdkVQ?oc=5","date":"2015-11-10","type":"pipeline","source":"University of California, Berkeley","summary":"Haas to Honor Novartis CEO Joseph Jimenez, MBA 84, at Nov. 13 Gala - University of California, Berkeley","headline":"Haas to Honor Novartis CEO Joseph Jimenez, MBA 84, at Nov. 13 Gala - University of California, Berkeley","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}